Nosocomial fungal infections: epidemiology, diagnosis, and treatment

J Perlroth, B Choi, B Spellberg - Medical mycology, 2007 - academic.oup.com
Invasive fungal infections are increasingly common in the nosocomial setting. Furthermore,
because risk factors for these infections continue to increase in frequency, it is likely that …

The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts

SP Georgiadou, NV Sipsas, EM Marom… - Clinical infectious …, 2011 - academic.oup.com
The halo sign is a CT finding of ground-glass opacity surrounding a pulmonary nodule or
mass. The reversed halo sign is a focal rounded area of ground-glass opacity surrounded by …

[HTML][HTML] Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

AJ Ullmann, JM Aguado, S Arikan-Akdagli… - Clinical Microbiology …, 2018 - Elsevier
Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

RE Greene, HT Schlamm, JW Oestmann… - Clinical Infectious …, 2007 - academic.oup.com
Background. Computed tomography (CT) of the chest may be used to identify the halo sign,
a macronodule surrounded by a perimeter of ground-glass opacity, which is an early sign of …

Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the imaging working group for the revision and update of the consensus definitions …

BD Alexander, F Lamoth, CP Heussel… - Clinical Infectious …, 2021 - academic.oup.com
Background Clinical imaging in suspected invasive fungal disease (IFD) has a significant
role in early detection of disease and helps direct further testing and treatment. Revised …

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German …

M Ruhnke, G Behre, D Buchheidt, M Christopeit… - Mycoses, 2018 - Wiley Online Library
Invasive fungal diseases (IFD) are a primary cause of morbidity and mortality in patients with
haematological malignancies. These infections are mostly life‐threatening and an early …

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution

GP Rosen, K Nielsen, S Glenn, J Abelson… - Journal of Pediatric …, 2005 - journals.lww.com
The purpose of this study was to determine the incidence of fungal infections in pediatric
hematology and oncology (PHO) patients and to describe variations regarding site of …

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients

RJ Trof, A Beishuizen, YJ Debets-Ossenkopp… - Intensive care …, 2007 - Springer
During recent years, a rising incidence of invasive pulmonary aspergillosis (IPA) in non-
neutropenic critically ill patients has been reported. Critically ill patients are prone to develop …

[HTML][HTML] Diagnosis of invasive fungal infections in hematology and oncology—guidelines from the Infectious Diseases Working Party in Haematology and Oncology of …

M Ruhnke, A Böhme, D Buchheidt, O Cornely… - Annals of oncology, 2012 - Elsevier
Invasive fungal infections (IFIs) are a primary cause of morbidity and mortality in patients
with hematological malignancies. Establishing a definite diagnosis of IFI in …

Assessment of the clinical utility of serial β-d-glucan concentrations in patients with persistent neutropenic fever

M Ellis, B Al-Ramadi, M Finkelman… - Journal of medical …, 2008 - microbiologyresearch.org
The performance of the Fungitell assay was investigated in 100 patients with haematological
malignancy undergoing chemotherapy who developed antibiotic-unresponsive neutropenic …